ダウンロード数: 1268

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
60_543.pdf1.17 MBAdobe PDF見る/開く
タイトル: 京都大学病院での前立腺全摘術における神経温存適応基準構築に関する検討
その他のタイトル: Development of a Preoperative Criterion to Select Candidates for Nerve-Sparing Radical Prostatectomy at Kyoto University Hospital
著者: 水野, 桂  KAKEN_name
井上, 貴博  KAKEN_name
宮崎, 有  KAKEN_name
牧野, 雄樹  KAKEN_name
寺田, 直樹  KAKEN_name
小林, 恭  KAKEN_name
山﨑, 俊成  KAKEN_id
松井, 喜之  KAKEN_name
神波, 大己  KAKEN_name
吉村, 耕治  KAKEN_name
三上, 芳喜  KAKEN_name
小川, 修  KAKEN_name
著者名の別形: Mizuno, Kei
Inoue, Takahiro
Miyazaki, Yu
Makino, Yuki
Terada, Naoki
Kobayashi, Takashi
Yamasaki, Toshinari
Matsui, Yoshiyuki
Kamba, Tomomi
Yoshimura, Koji
Mikami, Yoshiki
Ogawa, Osamu
キーワード: Radical Prostatectomy
Nerve-sparing
発行日: Nov-2014
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 60
号: 11
開始ページ: 543
終了ページ: 547
抄録: Neurovascular bundle (NVB) preservation is a mandatory procedure to maintain erectile function of localized prostate cancer patients after radical prostatectomy (RP). However, in terms of cancer control, indications to select appropriate patients for nerve-sparing RP are still controversial. In this study, we examined the pathological findings of RP specimens to develop a preoperative criterion for NVB preservation during RP. The study included 76 patients who underwent RP at our institution from 2006 to 2008, and we retrospectively analyzed RP specimens pathologically. The distance between NVB and foci of prostate cancer was measured in 135 prostate sides, and preoperative factors which predict the distance of ≤2 mm was evaluated. Univariate analysis showed that side-specific positive biopsy core rate ≥33.3%, sidespecific maximum tumor length in biopsy core ≥5 mm and side-specific tumor involvement rate in biopsy core ≥50% was associated with the risk of the distance of ≤2 mm. Multivariate analysis revealed that sidespecific positive biopsy core rate ≥33.3% was the only significant predictor of the ipsilateral NVB-tumor distance ≤2 mm (p=0.0055, odds ratio 3.49). Based on this study, a nerve-sparing criterion of <33.3% side-specific percent positive biopsy core was developed at our institution. Prospective data on patients who were applied this criterion are needed to evaluate its clinical safety and feasibility.
著作権等: 許諾条件により本文は2015/12/01に公開
URI: http://hdl.handle.net/2433/192328
PubMed ID: 25511940
出現コレクション:Vol. 60 No. 11

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。